---
title: "A Journey Back to Normalcy: Q320 Hemostats and Sealants Market Recap"
description: SmartTRAK reports that in Q320, the US Hemostats and Sealants market began its recovery from the COVID-19 shutdown, embarking on the journey back to normalcy ...
---

[Medical Device and Wound Care News and Analysis Blog ](https://blog.smarttrak.com)

# [A Journey Back to Normalcy: Q320 Hemostats and Sealants Market Recap](https://blog.smarttrak.com/a-journey-back-to-normalcy-q320-hemostats-and-sealants-market-recap)

 Written by [Doug Devens](https://blog.smarttrak.com/author/doug-devens) | 12/7/20 2:58 PM

***<https://app.smarttrak.com/analysis/qs/56cca7f724af57e5ac1002a6f7e40489>The US market for Hemostats and Sealants began the journey back to normalcy, slipping -0.2% YoY in Q320, as elective surgeries began to be performed again. Hemostats led the charge with Sealants not far behind.  
***

As the US healthcare system begins to manage COVID-19 and elective procedures return toward pre-COVID-19 levels, the US Hemostats and Sealants market rebounded with a drop of only -0.2% YoY in Q320 according to SmartTRAK Financial Dashboard. Most manufacturers still experienced declines in Q320, but far narrower than the losses of Q220. [Ethicon*](https://app.smarttrak.com/companies/qs/72645) managed a +4.5% gain in Q320 while the other manufacturers essentially treaded water with respect to Q319.

Among the many topics covered in the comprehensive [Q320 US Hemostats and Sealants Market Recap](https://app.smarttrak.com/analysis/qs/56cca7f724af57e5ac1002a6f7e40489)[*](https://app.smarttrak.com/analysis/qs/56cca7f724af57e5ac1002a6f7e40489) are:

- Complete US Hemostats & Sealants Market Overview
- Companies' Revenue and Market Shares
- Biosurgery Market Regains Its Footing
- Absorbable Hemostats Lead The Charge Back
- Fibrin Sealants Lead The Recovery
- Q320 Regulatory Events and Clinical Trials

As before the COVID-19 downturn, Ethicon continued to lead the overall US Hemostat and Sealants market in Q320 and managed to post a gain of +4.3% YoY to $MM* in revenue and 42.7% market share, in large part due to its widespread presence in hospitals where it could take advantage faster of the recovery in procedures. A recovering Baxter nonetheless fell behind Ethicon, while [Becton Dickinson*](https://app.smarttrak.com/companies/qs/72844) (BD) in third place gained slightly on Baxter, posting revenue of ...

[**Read the entire Q320 US Hemostats and Sealants ** **Market Recap including news, data, charts, company revenues, shares and analysis**](https://app.smarttrak.com/analysis/qs/56cca7f724af57e5ac1002a6f7e40489)[*](https://app.smarttrak.com/analysis/qs/56cca7f724af57e5ac1002a6f7e40489)

*The entire article and the links can only be viewed by [SmartTRAK ](https://www.smarttrak.com/)subscribers to this module. For more information on how to receive a demo and subscribe, please [click](https://landing.smarttrak.com/request-demo) the button below.

<https://www.smarttrak.com/>

[SmartTRAK](https://www.smarttrak.com/) is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis. Used by the 15 top Advanced Wound Care companies and 8 of the 10 top Orthopedic companies, SmartTRAK transforms the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost.

[View full post](https://blog.smarttrak.com/a-journey-back-to-normalcy-q320-hemostats-and-sealants-market-recap)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Doug Devens"
  },
  "dateModified" : "2020-12-07T14:58:41.769Z",
  "datePublished" : "2020-12-07T14:58:41Z",
  "headline" : "A Journey Back to Normalcy: Q320 Hemostats and Sealants Market Recap",
  "image" : {
    "@type" : "ImageObject",
    "height" : 512,
    "url" : "https://f.hubspotusercontent00.net/hubfs/3044256/Q320%20H&S.png",
    "width" : 1024
  },
  "mainEntityOfPage" : "https://blog.smarttrak.com/a-journey-back-to-normalcy-q320-hemostats-and-sealants-market-recap",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://cdn2.hubspot.net/hubfs/3044256/SmartTRAK%202.0%20Logo%20Art/SmartTRAK%20Logo%20Email250.png",
      "width" : 187.5
    },
    "name" : "SmartTRAK Life Sciences News and Analysis Blog"
  }
}
```